PRIM holds its 2023 Ordinary General Shareholders’ Meeting where innovation and strategic alliances are the main protagonists

The medical technology company saw 17% growth in 2022, which is far beyond the 4% figure seen in the market as a whole It reached €197 million in revenue last year, confirming the success of its 21/25 Strategic Plan The PRIM Group…